Venus recently received Good Manufacturing Practices (GMP) Certification from Saudi Arabia for all its production facilities at its Baddi, Himachal Pradesh unit, thus taking the organization's total global GMP certifications to 20. The Saudi Food and Drug Authority (SFDA) while granting this certification also renewed the approval for Cephalosporin and

Venus has been working on target-based drug delivery for cancer treatment and diagnostics. The company has recently received marketing authorizations for its cancer drugs from Uzbekistan and Palestine. It has received marketing approval for Carboplatin in Uzbekistan and Docetaxel and Irinotecan in Palestine. With over 800 marketing authorizations worldwide, this

Venus emerged as the first pharma company in the country to have received the prestigious Responsible Export Organisation (REO) Certification from the Confederation of Indian Industry (CII) following an elaborate screening and assessment process. The certification is an endorsement of the company’s export capabilities and manufacturing prowess. It will

Venus received the coveted Good Distribution Practices (GDP) Certification (WHO TRS 957 ANNEX-5) for quality services throughout the Supply Chain Cycle, i.e., from product manufacturing to delivery to end-consumer. SGS (Société Générale de Surveillance) is the world’s leading testing, inspection and certification company. SGS awarded this remarkable certification